The Blood–Brain Barrier and Epilepsy

@article{Oby2006TheBB,
  title={The Blood–Brain Barrier and Epilepsy},
  author={E. Oby and D. Janigro},
  journal={Epilepsia},
  year={2006},
  volume={47}
}
Summary:  During the past several years, there has been increasing interest in the role of the blood–brain barrier (BBB) in epilepsy. Advances in neuroradiology have enhanced our ability to image and study the human cerebrovasculature, and further developments in the research of metabolic deficiencies linked to seizure disorders (e.g., GLUT1 deficiency), neuroinflammation, and multiple drug resistance to antiepileptic drugs (AEDs) have amplified the significance of the BBB's relationship to… Expand
The Blood-Brain Barrier in Epilepsy
TLDR
Three critical components of barrier function 1) tight junctions, 2) metabolising enzymes and 3) transporter proteins are introduced and it is described how they are changed in epilepsy and affected by epilepsy treatment. Expand
Blood–brain barrier dysfunction and epilepsy: Pathophysiologic role and therapeutic approaches
TLDR
A BBB‐centric view of seizure disorders is offered, linking several aspects of seizures and epilepsy physiopathology to BBB dysfunction, and the therapeutic, antiseizure effect of drugs that promote BBB repair is reviewed. Expand
Blood–brain barrier damage and brain penetration of antiepileptic drugs: Role of serum proteins and brain edema
TLDR
Increased blood–brain barrier permeability is radiologically detectable in regions affected by drug‐resistant epileptogenic lesions and the hypothesis that lipophilic and hydrophilic drug distribution is differentially affected by BBB damage is tested. Expand
Status epilepticus, blood–brain barrier disruption, inflammation, and epileptogenesis
TLDR
How the BBB is disrupted as a consequence of SE and how this BBB breakdown may be involved in epileptogenesis is discussed. Expand
Role of blood–brain barrier in temporal lobe epilepsy and pharmacoresistance
TLDR
The role of the BBB in TLE and drug resistance is discussed, potential new therapies that may restore normal BBB function in order to put a brake on epileptogenesis and/or to improve drug treatment are summarized and summarized. Expand
ANTIEPILEPTIC DRUGS | Pathways of Drug Diffusion into the Epileptic Brain
TLDR
There have been no major improvements in the reduction of the total number of drug-resistant patients and this lack of progress underscores the nonspecificity of the refractory process itself, suggesting that rather general mechanisms may affect the efficacy of all available AEDs. Expand
Blood-Brain Barrier Dysfunction in Epileptogenesis of the Temporal Lobe
TLDR
New evidence is provided to support the hypothesis that BBB breakdown and specifically exposure of temporal lobe structures to the most common serum protein, albumin, is sufficient to induce epileptogenesis. Expand
The blood–brain barrier in health and disease
  • R. Daneman
  • Biology, Medicine
  • Annals of neurology
  • 2012
TLDR
This review discusses the cellular and molecular composition of the blood–brain barrier and how the development and function of the BBB is regulated by interactions with the CNS microenvironment. Expand
Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders.
TLDR
Evidence that mast cells and the release of factors such as histamine play an important role in the neuroinflammatory process associated with brain disorders such as Alzheimer's disease, Parkinson's disease and epilepsy is presented. Expand
The Etiological Role of Blood-Brain Barrier Dysfunction in Seizure Disorders
TLDR
Blood-brain barrier dysfunction is an important etiological player in seizure disorders, and combination therapies utilizing an AED in conjunction with a “cerebrovascular” drug could be used to control seizures more effectively than AED therapy alone. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 190 REFERENCES
Epilepsy and the blood-brain barrier.
TLDR
Indirect evidence is available to suggest that during seizures, BBB transport may indeed be the rate-limiting step, and glucose availability to the seizing brain may be restricted to such a degree that brain glucose utilization rates are no longer independent of plasma glucose levels. Expand
Overexpression of Multiple Drug Resistance Genes in Endothelial Cells from Patients with Refractory Epilepsy
TLDR
It was suggested that altered drug permeability across the blood–brain barrier (BBB) may be involved in pharmacoresistance to antiepileptic drugs (AEDs) and multiple drug resistance (MDR) gene expression in endothelial cells isolated from temporal lobe blood vessels of patients with refractory epilepsy was measured. Expand
Drug resistance in epilepsy: the role of the blood-brain barrier.
TLDR
Evidence that under pathological conditions, 'second line defence' mechanisms in perivascular glia may be up-regulated, including expression of Pgp and other drug efflux transporters complicates interpretation of drug resistance in epilepsy, and therapeutic strategies is found. Expand
Reading and writing the blood-brain barrier: relevance to therapeutics.
TLDR
These techniques for both "reading" and "writing" the BBB will help new and old medications to reach their pharmacological targets in the CNS. Expand
The blood–brain barrier: an overview Structure, regulation, and clinical implications
TLDR
The pathogenesis of increased BBB permeability in hypoxia-ischemia and inflammatory mechanisms involving the BBB in septic encephalopathy, HIV-induced dementia, multiple sclerosis, and Alzheimer disease are described. Expand
Frequent Blood–Brain Barrier Disruption in the Human Cerebral Cortex
Abstract1. The blood–brain barrier (BBB) protects the brain from circulating xenobiotic agents. The pathophysiology, time span, spatial pattern, and pathophysiological consequences of BBB disruptionsExpand
The blood-brain barrier as a target for pharmacological modulation.
TLDR
The endogenous iron/transferrin transport system has been used extensively preclinically to deliver intravenously administered nerve growth factor to the brain and serves as the major focus for this discussion. Expand
Lasting Blood-Brain Barrier Disruption Induces Epileptic Focus in the Rat Somatosensory Cortex
TLDR
This study established a model for focal disruption of the blood-brain barrier in the rat cortex by direct application of bile salts and found that a focus of epileptiform discharges developed within 4-7 d after treatment and could be recorded up to 49 d postoperatively in >60% of slices from treated animals but only rarely in sham-operated controls. Expand
Molecular and cellular mechanisms of pharmacoresistance in epilepsy.
TLDR
An emerging understanding of the molecular underpinnings of both transporter- and target-mediated mechanisms of pharmacoresistance in human and experimental epilepsy is likely to provide important impetus for the development of new pharmacological treatment strategies. Expand
Blood–brain barrier, ion homeostasis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms
TLDR
It is hypothesized that one of the mechanisms of the ketogenic diet in epilepsy may relate to increased availability of beta-hydroxybutyrate, a ketone body readily transported at the BBB, supported by the fact that theketogenic diet is the treatment of choice for the glucose transporter protein syndrome and pyruvate dehydrogenase deficiency. Expand
...
1
2
3
4
5
...